Theme: Exceeding the Vision in Drug and Pharmaceutical Chemistry
Pharm Chem 2018
ME Conferences invites all the participants across the globe to attend 20th world conference on pharmaceutical chemistry and Drug Design during December 10-11, 2018 at Dubai which includes innovative keynote presentations, lectures, Poster presentations and workshops or symposiums. Pharm Chem 2018 Congress is a specially designed gathering Pharmaceutical and Medicinal Chemistry Conference. The main theme of this Pharma conferences is “Exceeding the vision in drug and pharmaceutical chemistry” which covers a wide range of critically important sessions.
Why to attend?
Enable participants to exchange ideas and expand network with leading pharmaceutical scientists and professionals. Drug pharma chemistry 2018 brings together top international scientists and professionals presenting cutting edge discoveries, research and new therapeutic drugs. Enable exhibitors to have increased visibility through branding and networking at the conference and gain direct access to a core audience of professionals and decision makers.
Pharmaceutical Organic Chemistry
Drug Target Discovery
Pharmaceutical Drug Discovery and Nanotechnology
Materialistic Chemistry & Synthetic Chemistry
Cancer Research in Medicinal Chemistry
Computer Aided Drug Design-CADD
Pharma Medicinal Chemistry
Chemoinformatic Drug Discovery
Clinical Trials and Regulatory Affairs in Pharmacy
Novel Drug Target Approaches
Novel Drug Delivery System in pharmaceutics
Proteomics & Bioinformatics Drug Discovery
Track 1: Drug Designing
Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bimolecular targets. The drug is an organic molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit.Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bimolecular targets. The drug is an organic molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit Pharmaceutical Chemistry Meetings
Track 2: Pharmaceutical Organic Chemistry
Organic chemistry is a chemistry subdiscipline involving the scientific study of the structure, properties, and reactions of organic compounds and organic materials, i.e., matter in its various forms that contain carbon atoms. It includes many physical and chemical method to determine the compound and materials. Study of molecules includes both physical properties and chemical properties and uses similar methods, so as to evaluate chemical reactivity. The variety of compounds studied in organic chemistry include hydrocarbons, as well as myriad compositions based always on carbon. In addition, organic chemistry involves further organometallics the lanthanides, but especially transition metals (zinc, copper, nickel, cobalt, titanium and chromium).Drug chemistry Conferences
Track 3: Drug Target Discovery
The term drug targets regularly used in medicinal research to describe the native protein in the body whose activity is modified by a drug resulting in a distinct effect, which may be a desirable therapeutic effect or an unwanted side effect. In this context, the biological target is often referred to as a biological target. The most common drug targets are G-protein couple receptor, enzymes, ligand gated channels, voltage gated channels, ion channels, nuclear hormone receptor and membrane transport proteins.Pharma Events
Track 4: Pharmaceutical Drug discovery and Nanotechnology
Nanotechnology has now introduced to develop medicine. Nanotechnology contains the use of materials with essential length scales in the nanometer measurement which demonstrate significantly changed properties associated to micron structured materials. Such materials can include particles, fibers, grain sizes, etc. This session highlighted the progressions nanotechnology is making in medicine in such fields as disease prevention, diagnosis, and treatment including (but not limited to) drug delivery, tissue engineering, implants, sensors, cancer treatment, an but not limited to) drug delivery, tissue engineering, transplants, sensors, cancer treatment, and toxic.Pharmaceutical Chemistry Meetings
Track 5: Pharmacovigilance
Pharmacovigilance is that branch of pharmacology that focuses on analysis, detection and prevention of adverse effects caused by pharmaceutics. Adverse drug reactions (ADRs) are a major cause of patient related morbidity and mortality. Reporting of ADRs is considered to be an important step in maintaining and achieving a safe drug therapy use. Nowadays, Pharmacovigilance hugely emphasizes on challenges like Mass treatment regimens, Un-labelled and Off-labelled indications, Nutritional aspects, New drugs, Adherence, Co-morbidities and Drug resistances. Medication errors such as misuse, overdose, abuse of a drug and drug exposure are some of the reasons responsible for ADRs. The main objective is to generate independent, evidence-based recommendations on the safety of medicines and to monitor benefit-risk profile of different pharmaceutics. Pharma Chem Conference
Track 6: Enzyme Reaction
Enzyme reaction is the increase in the amount of a chemical reaction by the active site of a protein. The protein catalyst (enzyme) may be part of a multi-subunit compound, and/or may rapidly or permanently associate with a Cofactor (example: xylose). Catalysis of enzyme reactions in the cell is vigorous due to the very low reaction rates of the uncatalyzed reactions at room temperature and pressure. A main driver of protein development is the optimization of such catalytic activities via protein dynamics. The mechanism of enzyme catalysis is analogous in principle to other types of chemical catalysis. By provided that an alternative reaction routes the enzyme reduces the energy required to reach the highest energy transformation state of the reaction. The reduction of activation energy increases the quantity of reactant molecules that achieve a sufficient level of energy, such that they reach the activation energy and form the product.Pharmaceutical Chemistry Congress
Track 7: Materialistic Chemistry & Synthetic Chemistry
The character of atoms and the changes that occur at intermissions of such elements on the molecular level and non-natural chemistry of nanomaterials. Conversely, modification of peptide materials by Thiol-X chemistry additionally involves the techniques of those substances which are endued with intrinsic voids, ideal materials, and real materials. With the chemistry of tissue adhesive materials, there are endless prospects for making numerous properties of medicative chemistry with carbons and fullerene derivatives. Biological chemistry isn't just involved with the revelation of biological phenomena to Materialistic Chemistry is a discipline of frontiers in inorganic synthetic chemistry that seeks to reveal utilize the studies of drug design and drug discovery. The artificial medicative chemistry endeavors to form new technology which will form the commercial foundation to alter North American country to foster a wholesome natural perspective and philosophy and a healthy property society.Pharmaceutical Chemistry Conferences
Track 8: Cancer Research in Medicinal Chemistry
The term "cancer" refers to a group of diseases that include irregular cell growth with the latent spread to other parts of the body. As each cancer consists of a various cell types highly effective at developing confrontation to both drug and radiation therapy, it is a particularly difficult disease to treat. The challenge for the field of medicinal chemistry is to design drugs capable of selectively targeting cancer cells while evading multidrug resistance pathways. Using recent observations into the unique attributes of cancer cells, Medicinal Chemistry is pursuing anti-tumor agents of high specificity to help design appropriately targeted, selective chemotherapeutics. Current programs involve a various array of anti-cancer targets, such as lipid and protein kinases, microtubules, topoisomerases, hypoxia inducible factors, bromodomains and histone acetyltransferases.DrugPharma Conferences
Track 9: Computer Aided Drug Design-CADD
Computer aided drug design and Advanced Instrumentation is that the most basic goal is to predict whether a given bioactive molecule can bind to a target or not. Study in drug design or biomarkers in drug design measures the conformation of the little molecule and to model conformational changes within the biological target which will occur once the little molecule binds thereto. Recent advances in CADD with the utilization of high performance computing technology and Insilco molecular design computer code and tools offer might optimize the parameters for the molecular mechanics calculations and additionally provide an estimation of the electronic properties (electrostatic potential, polarizability, etc.) of the drug molecule that may influence binding affinity within the use of ultrasound in medicinal chemistry. High-resolution 1H-NMR chemical analysis and X-Ray absorption chemical analysis ways may additionally be accustomed offer semi-quantitative prediction of the required affinity.Pharmaceutical Meetings
Track 10: Pharma Medicinal Chemistry
The margins between present developments in medicinal chemistry and investigative medicinal chemistry between inanimate and living matter may be a major feature of the convergence between engineering and biotechnology. The most intention of recent advances in medicinal chemistry is to emphasize that though creating life may be a continual project which measures refined process within the underlying hypothetical assumptions. This comparison is supposed to contribute to an improved understanding of the cultural problems at stake within the convergence between Nano and biotechnologies. It suggests that the limit between life and inanimate matter remains a stock in which the advancement in Pharmacogenomics and Pharmacoproteomic research on drugs will tends to new discoveries.Pharma Meetings
Track 11: Chemoinformatic Drug Discovery
Chemoinformatics plays a vital link between made-up design and in drug design through mining of information from the data and translate into knowledge. Derivation of information and knowledge is only one aspect of chemoinformatic. The use of consequent knowledge in a design and selection support role is an important part of the drug design cycle. The main processes within drug discovery are lead documentation, where a lead is something that has activity in the low micro molar range, and lead optimization, which is the process of transforming a lead into a drug candidate. Chemo informatics methods can be used proactively to designing and filter the most appropriate compounds to work within the real world Drug Chemistry Conferences
Track 12: Clinical Trials and Regulatory Affairs in Pharmacy
Clinical trials are tests done in clinical research. Such ultimate biomedical or interactive research studies on human participants are designed to answer precise questions about biomedical or behavioral interferences, with new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that certification further study and comparison. Clinical trials generate data on safety and efficacy.
Regulatory affairs are completely a new profession which established from the desire of governments to secure public health by monitoring the protection and value of products in areas together with pharmaceutical, pesticides, medical devices, agrochemicals, cosmetics and other related medicines.Drug Pharma Events
Track 13: Novel Drug Target Approaches
Categorizing drug targets plays crucial roles in designing new drugs and opposing diseases. Unfortunately, our current understanding about drug targets is far from complete. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets. Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for most important social and health disorder as millions of people are dying every year. Out of which, atherosclerosis is the leading cause of deaths globally. The lipid irregularity is one of the most important adjustable risk factors for atherosclerosis. Both genetic and conservation components are associated with the development of atherosclerotic signs.Pharma Meetings
Track 14: Novel Drug Delivery System in Pharmaceutics
The process by which a drug is distributed can have a important effect on its efficacy Some drugs have an optimum concentration range within which extreme benefit is derived, and concentrations above or below this range can be noxious or produce no therapeutic benefit at all. On the other hand, the very slow improvement in the efficacy of the treatment of severe diseases, has optional a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. These nanoparticles would be loaded with drugs and plagued to specific parts of the body where there is completely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a targeted drug delivery system is to extend, localize, target and have a vulnerable drug interaction with the diseased muscle.Pharmaceutical Chemistry Meetings
Track 15: Proteomics & Bioinformatics Drug Discovery
Proteomics, the large-scale analysis of proteins, contributes expressively to our understanding of gene function in the post-genomic era. Proteomics can be divided into three main areas: (1) protein micro-characterization for large-scale certification of proteins and their post-translational changes; (2) 'differential display' proteomics for comparison of protein levels with potential application in a extensive range of diseases; and (3) studies of protein–protein interactions using methods such as mass spectrometry or the yeast two-hybrid system. Proteomics technologies are under nonstop progresses and new skills are introduced. Nowadays high quantity acquisition of proteome data is possible.Pharma Events
Track 16: Pharmacy Marketing
The Present Marketing practice in the Pharmaceutical sector, examining both customer and doctor slanted towards promotion. The present examples of marketing practices and their impact on consumer and doctor behavior. It identifies negative impact of these practices which include misleading advertising, disease shove and escalating costs. It goes on to maintain the need for an independently monitored code of practice for marketers in the pharmaceutical sector and a great degree of consumer education for both end users and those Prescribing drugs.Drug Pharma Conferences
Scope and Importance:
The pharmaceutical business speaks to a standout among the most dynamic and requesting ventures on the planet. As human services keep on developing and record for a noteworthy bit of the economy in the United States and all through the world, the significance of the pharmaceutical and social insurance industry increments. The Pharma Industry are in charge of advancement, generation and advertising of drugs. Throughout the years drug store has developed as pharmaceuticals sciences through innovative work forms. It is identified with item and in addition to administrations. The different medications found and created are its items and the human services it gives goes under the class of administrations.
Why in Dubai:
Dubai is the most crowded city in the United Arab Emirates (UAE). It is located on the southeast shore of the Persian Gulf and is one of the seven emirates that make up the nation. The city of Dubai is located on the emirate's northern seashore and heads up the Dubai-Sharjah-Ajman metropolitan territory. Dubai is to host World Expo 2020.Dubai has risen as a worldwide city and business center of the Middle East. It is additionally a noteworthy transport center for travelers and payload. By the 1960s, Dubai's economy depended on incomes from exchange and, to a littler degree, oil investigation concessions, yet oil was not found until 1966. Oil income initially began to stream in 1969. Dubai's oil income quickened the early advancement of the city, yet its stores are controlled, and creation levels are low: today, under 5% of the emirate's income originates from oil. The emirate's Western-style model of business drives its economy with the primary incomes now originating from tourism, flying, land, and monetary administrations. The most understood colleges in Dubai are American University in Dubai, Halt International Business School, Al Ghurair University, The American College of Dubai, University of Wollongong in Dubai, British University in Dubai offering courses in Business Administration, Engineering, Architecture and Interior Design. American University in Dubai is one of the six UAE colleges highlighted in QS World University Rankings 2014/2015. In 2013 Synergy University Dubai Campus opened its grounds in Jumeirah Lakes Towers being a first University in Dubai to situated outside of Educational Zones.
Dubai investment in Globalpharma was well timed, as they profited on the rapid growth in the pharmaceutical sector in the region. It manufactures medicines such as antibiotics, cardiovascular, painkillers, food supplements, vitamins and anti-allergic formulations and others. The outlook cost of the medicines in Dubai, is highest among the Middle East The pharmaceutical market in the United Arab Emirates (UAE) is set to grow from just over AED 9.6 billion in 2016 and are estimated to grow around AED 13 billion, Another major trend is the growth of local production of pharmaceuticals which is estimated to grow at a CAGR of around 10% from 2015 to 2018., driven by increased healthcare expenditure, mandatory health insurance, and growing medical tourism. According to research and checking firm Global Data’s latest report, the UAE is rapidly gaining popularity as a medical tourism destination due to its low costs, English-speaking medical staff, and nearly non-existent queues for treatment. Indeed, the Dubai Health Authority is working to develop the medical tourism sector, aiming to attract 1.3 million medical tourists annually by 2021. One major initiative of the UAE government is its encouragement to private sector involvement and investment with the ultimate aim of refining healthcare. To this end, the government has established the Dubai Healthcare City and Dubai Science Park, which are special zones that come with 100% tax renovation and foreign ownership.
Professors, Associate Professors, Assistant Professors.
Directors, CEO’s of Organizations.
Graduates and Post Graduates.
Association, Association presidents and professionals.
Noble laureates in Health Care and Medicine.
Bio instruments Professionals.
Software development companies.
Research Institutes and members.
Supply Chain companies.
CRO and DATA management Companies.
PhD Scholars & Researchers
List of Pharmaceutical Companies in Dubai:
Life Pharma FZE
Pharma Service Company
Globalpharma - A Sanofi Company
Pharma trade L.L.C.
Aster (Aster One) Pharmacy
IDS - Al I ttihad Drug Store
Ranbaxy Laboratories Limited
Astra Zeneca UAE
Societies Associated with United Arab Emirates:
Aweer Society Pharmacy
Safa Society Pharmacy
5th International Congress of the Emirates Neurology Society (EMINS).
Aster Al Aweer Pharmacy
International Society of Oncology Pharmacy Practitioners
European Industrial Pharmacists Group; European Pharmaceutical Students Association; Pharmaceutical Group of the European Union; European Association of Hospital Pharmacists; European Confederation of Pharmaceutical Entrepreneurs; European Generic Medicines Association; European Federation of Pharmaceutical Industries and Associations ;European Pharmaceutical Market Research Association; Pharmaceutical Society of New Zealand; Major Pharmacists Associations in Australia; Australian Friendly Societies Pharmacies Association; Australian Health Practitioner Regulatory Agency; Pharmacy Board of Australia; Australian Pharmacy Council; Professional Pharmacists Australia; Pharmacy Division of Professionals Australia; Pharmaceutical Society of Australia; The Pharmacy Guild of Australia; The Society of Hospital Pharmacists of Australia; European Association of Employed Community Pharmacists in Europe; European Pharmaceutical Union; Pharmaceutical Group of the European Union; Australian College of Pharmacy; Pharmaceutical Society of Australia; The Pharmacy Guild of Australia; The Society of Hospital Pharmacists of Australia; Irish Pharmaceutical Healthcare Association ;
New York Health Products Council; Pharmaceutical Research and Manufacturers of America ; American Association of Colleges of Pharmacy; American Society of Consultant Pharmacists ; American Society of Health-System Pharmacists; Professional Compounding Centers of America; Canadian Pharmacists Association; Canadian Society of Hospital Pharmacists; American Association of Colleges of Pharmacy; American Pharmacists Association; American Society for Pharmacy Law; American Society of Health-System Pharmacists; Professional Compounding Centers of America; American College of Clinical Pharmacy; Global Alliance for Pharmacy Education; International Pharmaceutical Federation; Drug Information Association;
Scientific Centre of Drug and Medical Technology Expertise; National Health Regulatory Authority; Ministry of Health - Pharmaceutical Services; Egyptian Drug Authority; Georgia Drugs and Narcotics Agency; Jordan Food and Drug Administration; Kuwait Drug and Food Control Administration; Pharmacy and Drug Control
Chinese Pharmaceutical Association; Indian Pharmacist Association; Pakistan Pharmacists Association; Japan Pharmaceutical Manufacturers Association; Association of Pharmacy Professionals; Pharmaceutical Association of Mauritius ; The Pharmaceutical Association of Israel; Kuwait Pharmaceutical Association; Drug Office - Department of Health; Pharmaceuticals and Medical Devices Agency; Ministry of Food and Drug Safety; Directorate General of Drug Administration; Central Drugs Standard Control Organization; National Agency of Drug and Food Control; National Pharmaceutical Control Bureau; Drug Administration of Vietnam; Ministry of Health - Pharmaceutical Services; Egyptian Drug Authority; General Directorate of Pharmacy; Pharmacy and Drug Control; National Information and Analytical Center on Drugs Control; Pharmaceutical Services Standards Branch - National Department of Health;
Related Conferences: 5th Chemistry in Drug Discovery and Designing Conferences, April 16-17, 2018 Dubai , UAE; 18th Medicinal and Pharmaceutical Chemistry Conferences, July 19-21, 2018 Dubai, UAE; 17th Medicinal and Pharmaceutical Sciences Conferences, July 05-06, 2018 Bangkok, Thailand; 6th Pharmacognosy, Phytochemistry and Natural Products Conferences, September 12-13, 2018 Shanghai, China; 2nd Pharmaceutical Development and Technology Conferences, May 11-12, 2018 Tokyo, Japan; 13th Pharmacology and Toxicology Conferences, May 24-25, 2018 Tokyo, Japan; CPhI Middle East and Africa, September 03-05, 2018 Abu Dhabi; 12th Pharmacoepidemiology and Clinical Research, October 17-18, 2018 Seoul, South Korea; 11th European Biosimilars Congress, April 26-27, 2018 Rome, Italy; 13th Pharmacology and toxicology Conferences. May 24-25, 2018 Osaka, Japan; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 7th International Conference on Clinical Trials, September 24-26, 2018 Chicago, USA; 32nd Forensic Chemistry Conferences, September 26-27, 2018 Chicago, USA; 7th Global Advances in Mass Spectrometry, September 17-18, 2018 Singapore; Malaysia; 34th Pharmaceuticals and Nutraceuticals Conferences Oct 31- Nov 01, 2018 San Francisco; EAFP Annual Conferences 2018, May 16-18,2018 Parma, Italy; VIII International Meetings of Community Pharmacists, May 26 -28,2018 Alicante, Spain; The 2019 EAFP Annual Conference Krakow, Poland; International Pharma Conference and Expo May 2-4, 2018 Rome, Italy.
Pharmaceutical Chemistry 2017 Report:
We gratefully thank all our wonderful Keynote and Plenary Speakers, Conference Attendees, Students, Media Partners and Associations for making Pharmaceutical Chemistry 2017 grand success.
The 2nd International Conference on Pharmaceutical Chemistry hosted by the ConferenceSeries was held during October 02-04, 2017 at TRYP Barcelona Aeropuerto, Barcelona, Spain based on the theme “Recent Trends and Advancements in the fields of Pharma and Chemistry ". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from the area of Pharmaceutical Chemistry, Chemistry and Analytical science, who made this event a grand success.
ME Conferences expresses its gratitude to the conference Moderator, namely Dr. Matthew D. Lloyd from University of Bath, UK and Dr. Sundaram Singh from Indian Institute of Technology (BHU), India for taking up the responsibility to coordinate during the sessions. We are indebted to your support. Similarly we also extend our appreciation towards our Poster judges namely, Dr. Catherine Guillou, University of Paris-Saclay, France and Dr. Xianglin Shi, Chemical Process R&D, Biogen Idec, USA
ME Conferences would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Pharmaceutical Chemistry 2017:
Catherine Guillou, University of Paris-Saclay, France
Xianglin Shi, Chemical Process R&D, Biogen Idec, USA
Mark McLaughlin, Merck Sharp & Dohme, USA
Gervais Bérubé, Université du Québec à Trois-Rivières, Canada
Larisa Klapshina, Nizhny Novgorod State University, Russia
Fabio Marinelli, University of L’Aquila, Italy
Alexander V. Sirotkin, Constantine the Philosopher University, Slovakia
ME Conferences offers its heartfelt appreciation to organizations such as our esteemed Media Partners, Exhibitors, and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. It also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Co-chairs who supported this event.
Best Poster Awards Winners:
- Nikolay S. Zimnitskiy, Ural Federal University, Russia
- Mohammed Alqarni, De Montfort University, UK
- Shih-Chieh Yen, Development Center for Biotechnology, Institute of Pharmaceutics, Taiwan
With the grand success of Pharmaceutical Chemistry 2017, is proud to announce the " 20th World Conference on Pharmaceutical Chemistry and Drug Design" to be held during December 10-11, 2018 at Dubai, UAE.
Let us meet again @ Pharm Chem 2018
- Drug Designing
- Pharmaceutical Organic Chemistry
- Drug Target Discovery
- Pharmaceutical Drug Discovery and Nanotechnology
- Enzyme Reaction
- Materialistic Chemistry & Synthetic Chemistry
- Cancer Research in Medicinal Chemistry
- Computer Aided Drug Design-CADD
- Pharma Medicinal Chemistry
- Chemoinformatic Drug Discovery
- Clinical Trials and Regulatory Affairs in Pharmacy
- Novel Drug Target Approaches
- Novel Drug Delivery System in pharmaceutics
- Proteomics & Bioinformatics Drug Discovery
- Pharmacy Marketing
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
|Conference Date||December 10-11, 2018|
|Sponsors & Exhibitors||
|Speaker Opportunity Closed||Day 1||Day 2|
|Poster Opportunity Closed||Click Here to View|
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by
“It was very well organized and the venue did provide the proper environment for an effective exchange of new information and above all for inspiring discussions of scientific issues.”Volkmar Weissig, Midwestern University, USA
“I have found it interesting because they have had a diversity of different talks related to chemistry and formulations. It is a good opportunity to know new people interesting in the same field. I hope in the future I could come and share my contributions in Nanotechnology related to vaccinations.”Jose Crecente Campo, CiMUS, Spain
“I thank the Organizers for organizing such a wonderful conference. We have got a chance to meet several people from Academia and also Industry and also communicate with all the attendees. I highly recommend this conference to CRO’s, companies and also to our fellow colleagues and Sponsors. We will participate in future conferences too.”Mohammed Khalil, ACDIMA, Jordan
“Recently I have been attending many conferences of this Organization and I enjoyed these conferences as it interacts lot of people from different countries and also very good for Networking. The conference OCM selected very good people with good subjects and also good audiences. It enhances to exchange knowledge.”Osama Ibrahim, BioInnovation, USA
“I am quite happy to be here at this conference which is very well organized and also at a very nice place. It brings together people from different disciplines around pharmaceutics. It was also quite interesting to know the application and problems that might relate to solubility and pharmaceutical substances. I am looking forward to the next conference.”Gabriele Sadowski, TU Dortmund, Germany